Basic Information
| LncRNA/CircRNA Name | UCA1 |
| Synonyms | NA |
| Region | GRCh38_19:15828206-15836326 |
| Ensemble | ENSG00000214049 |
| Refseq | NR_015379 |
| Regulatory Mechanism | Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Information of Cancer
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | RNA-seq |
| Sample | BlCa tissues |
| Expression Pattern | up-regulated |
| Function Description | UCA1 was significantly overexpressed in bladder tumors compared with normal urothelium, which was confirmed only in the case of NMIBC. |
| Pubmed ID | 30815670 |
| Year | 2019 |
| Title | Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer. |
External Links
| Links for UCA1 | GenBank HGNC Noncode |
| Links for bladder cancer | Omim Cosmic |